Codexis CDXS
NASDAQ CDXS
$1.67 +0.09 (+5.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Codexis (CDXS) Cash from Investing Activities (2010 - 2026)

Codexis (CDXS) posted quarterly Cash from Investing Activities of -$1.1 million for Q1 2026, down 109.44% year-over-year from $11.8 million in Q1 2025, and down 119.45% quarter-over-quarter from $5.7 million in Q4 2025.

Codexis (CDXS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Codexis' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 109.44% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $10.6 million (up 163.8% YoY), while the FY2025 annual figure was $23.5 million, up 141.25% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$1.1 million, down from $5.7 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $11.8 million in Q1 2025, with the low at -$28.6 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$1.1 million (2026), against an average of -$3.1 million.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 3245.45% in 2023, then sank 1624.19% in 2024.
  • Codexis' Cash from Investing Activities stood at $33000.0 in 2022, then surged by 3245.45% to $1.1 million in 2023, then sank by 359.33% to -$2.9 million in 2024, then surged by 299.55% to $5.7 million in 2025, then tumbled by 119.45% to -$1.1 million in 2026.
  • Business Quant data shows CDXS's Cash from Investing Activities at -$1.1 million in Q1 2026, $5.7 million in Q4 2025, and $6.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Codexis 152.06 Mn 97.14 Mn 11.40 Mn 175,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 175,000.00
Jun 30, 2026 175,000.00
Mar 31, 2026 -1.11 Mn
Mar 31, 2026 -1.11 Mn
Dec 31, 2025 5.71 Mn
Dec 31, 2025 5.71 Mn
Sep 30, 2025 6.39 Mn
Sep 30, 2025 6.39 Mn
Jun 30, 2025 -367,000.00
Jun 30, 2025 -367,000.00
Mar 31, 2025 11.77 Mn
Mar 31, 2025 11.77 Mn
Dec 31, 2024 -2.86 Mn
Dec 31, 2024 -2.86 Mn
Sep 30, 2024 1.53 Mn
Sep 30, 2024 1.53 Mn
Jun 30, 2024 -27.09 Mn
Jun 30, 2024 -27.09 Mn
Mar 31, 2024 -28.56 Mn
Mar 31, 2024 -28.56 Mn